51. Proposal of an in vitro thrombus-growth model for evaluating anticoagulants.
- Author
-
Sawaguchi Y, Yamamoto H, Itou S, Tachibana K, Ohnuma K, Kamada Y, and Nakajima T
- Subjects
- Blood Coagulation, Calcium Chloride pharmacology, Citrates pharmacology, Humans, Anticoagulants pharmacology, Thrombosis drug therapy, Thrombosis prevention & control
- Abstract
The general anticoagulant evaluation requires high expense equipment, reagents, and space. Therefore, not all laboratories can perform research related to anticoagulant. In this study, we propose a novel simple method "in vitro thrombus-growth model" that can evaluate anticoagulant ability by measuring weight. The in vitro thrombus-growth model is prepared by creating a "growth-clot" with citrate plasma, calcium chloride, and thrombin, and then pouring new citrate plasma onto it. The prepared growth-clots were increased in volume in citrated human plasma, including surpluses calcium chloride, which was released slowly, leading to clot coagulation around the plasma. As a result of evaluating the anticoagulant ability of direct thrombin inhibitor using this in vitro thrombus-growth model, it was confirmed that clot growth was suppressed in a concentration-dependent manner. Therefore, this thrombus-growth model is useful as a primary anticoagulant test that can to discover compounds with anticoagulant activity perform in any laboratory.
- Published
- 2022
- Full Text
- View/download PDF